-
Outcome Based Matching
Authors:
Jonathan Bates,
Alexander Cloninger
Abstract:
We propose a method to reduce variance in treatment effect estimates in the setting of high-dimensional data. In particular, we introduce an approach for learning a metric to be used in matching treatment and control groups. The metric reduces variance in treatment effect estimates by weighting covariates related to the outcome and filtering out unrelated covariates.
We propose a method to reduce variance in treatment effect estimates in the setting of high-dimensional data. In particular, we introduce an approach for learning a metric to be used in matching treatment and control groups. The metric reduces variance in treatment effect estimates by weighting covariates related to the outcome and filtering out unrelated covariates.
△ Less
Submitted 13 December, 2017;
originally announced December 2017.
-
DeepSurv: Personalized Treatment Recommender System Using A Cox Proportional Hazards Deep Neural Network
Authors:
Jared Katzman,
Uri Shaham,
Jonathan Bates,
Alexander Cloninger,
Tingting Jiang,
Yuval Kluger
Abstract:
Medical practitioners use survival models to explore and understand the relationships between patients' covariates (e.g. clinical and genetic features) and the effectiveness of various treatment options. Standard survival models like the linear Cox proportional hazards model require extensive feature engineering or prior medical knowledge to model treatment interaction at an individual level. Whil…
▽ More
Medical practitioners use survival models to explore and understand the relationships between patients' covariates (e.g. clinical and genetic features) and the effectiveness of various treatment options. Standard survival models like the linear Cox proportional hazards model require extensive feature engineering or prior medical knowledge to model treatment interaction at an individual level. While nonlinear survival methods, such as neural networks and survival forests, can inherently model these high-level interaction terms, they have yet to be shown as effective treatment recommender systems. We introduce DeepSurv, a Cox proportional hazards deep neural network and state-of-the-art survival method for modeling interactions between a patient's covariates and treatment effectiveness in order to provide personalized treatment recommendations. We perform a number of experiments training DeepSurv on simulated and real survival data. We demonstrate that DeepSurv performs as well as or better than other state-of-the-art survival models and validate that DeepSurv successfully models increasingly complex relationships between a patient's covariates and their risk of failure. We then show how DeepSurv models the relationship between a patient's features and effectiveness of different treatment options to show how DeepSurv can be used to provide individual treatment recommendations. Finally, we train DeepSurv on real clinical studies to demonstrate how it's personalized treatment recommendations would increase the survival time of a set of patients. The predictive and modeling capabilities of DeepSurv will enable medical researchers to use deep neural networks as a tool in their exploration, understanding, and prediction of the effects of a patient's characteristics on their risk of failure.
△ Less
Submitted 8 August, 2017; v1 submitted 2 June, 2016;
originally announced June 2016.
-
The embedding dimension of Laplacian eigenfunction maps
Authors:
Jonathan Bates
Abstract:
Any closed, connected Riemannian manifold $M$ can be smoothly embedded by its Laplacian eigenfunction maps into $\mathbb{R}^m$ for some $m$. We call the smallest such $m$ the maximal embedding dimension of $M$. We show that the maximal embedding dimension of $M$ is bounded from above by a constant depending only on the dimension of $M$, a lower bound for injectivity radius, a lower bound for Ricci…
▽ More
Any closed, connected Riemannian manifold $M$ can be smoothly embedded by its Laplacian eigenfunction maps into $\mathbb{R}^m$ for some $m$. We call the smallest such $m$ the maximal embedding dimension of $M$. We show that the maximal embedding dimension of $M$ is bounded from above by a constant depending only on the dimension of $M$, a lower bound for injectivity radius, a lower bound for Ricci curvature, and a volume bound. We interpret this result for the case of surfaces isometrically immersed in $\mathbb{R}^3$, showing that the maximal embedding dimension only depends on bounds for the Gaussian curvature, mean curvature, and surface area. Furthermore, we consider the relevance of these results for shape registration.
△ Less
Submitted 4 May, 2016;
originally announced May 2016.
-
Numerical algebraic geometry for model selection and its application to the life sciences
Authors:
Elizabeth Gross,
Brent Davis,
Kenneth L. Ho,
Daniel J. Bates,
Heather A. Harrington
Abstract:
Researchers working with mathematical models are often confronted by the related problems of parameter estimation, model validation, and model selection. These are all optimization problems, well-known to be challenging due to non-linearity, non-convexity and multiple local optima. Furthermore, the challenges are compounded when only partial data is available. Here, we consider polynomial models (…
▽ More
Researchers working with mathematical models are often confronted by the related problems of parameter estimation, model validation, and model selection. These are all optimization problems, well-known to be challenging due to non-linearity, non-convexity and multiple local optima. Furthermore, the challenges are compounded when only partial data is available. Here, we consider polynomial models (e.g., mass-action chemical reaction networks at steady state) and describe a framework for their analysis based on optimization using numerical algebraic geometry. Specifically, we use probability-one polynomial homotopy continuation methods to compute all critical points of the objective function, then filter to recover the global optima. Our approach exploits the geometric structures relating models and data, and we demonstrate its utility on examples from cell signaling, synthetic biology, and epidemiology.
△ Less
Submitted 1 April, 2016; v1 submitted 15 July, 2015;
originally announced July 2015.
